Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
STLN
HoldHot AirFLAGThe Oncology Institute, Inc. · Healthcare · United States · $629M · Avg Vol: $9M/d
Insufficient evidence for a screen-pass. The Oncology Institute, Inc.: fails the quant gate on quality, value (Q46/V30/M80; every leg must be >= 50). Absence of evidence is neutral; nothing adverse is known.
COMPANY DESCRIPTION
Starling Oncology, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 252.5M | 324.2M | 393.4M | 502.7M | 25.8% | 587.2M | 665.0M | 883.9M | 32.6% |
| EPS | 0.02 | -0.92 | -0.71 | -0.54 | — | -0.29 | -0.16 | — | — |
| Shares | 73.3M | 74.1M | 75.7M | 98.9M | +34.9% | 101.9M | — | — | — |
| Debt | 108.2M | 119.7M | 123.2M | 103.7M | -1.4% | 104.8M | — | — | — |
| Equity | 123.2M | 57.0M | 3.6M | -15.7M | -82.9% | — | — | — | — |
| Op CF | -61.8M | -36.3M | -26.5M | -24.6M | — | — | — | — | — |
| Inv CF | -131.6M | 62.6M | 46.2M | -3.1M | — | — | — | — | — |
| Fin CF | 92.2M | -6.8M | -3.5M | 11.6M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of STLN are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| STLN | The Oncology Institute, Inc.(you) | $629M | 63 | Hold |
| GMRS | GMR Solutions Inc. | $681M | 72 | Buy |
| USPH | U.S. Physical Therapy, Inc. | $1.2B | 62 | Hold |
| PNTG | The Pennant Group, Inc. | $1.3B | 64 | Hold |
| INNV | InnovAge Holding Corp. | $1.5B | 63 | Hold |
| CYH | Community Health Systems, Inc. | $413M | 73 | Buy |
| SRTA | Strata Critical Medical, Inc. | $528M | 41 | Hold |
| SGRY | Surgery Partners, Inc. | $1.8B | 58 | Hold |
| ACHC | Acadia Healthcare Company, Inc. | $2.7B | 57 | Hold |
| OPCH | Option Care Health, Inc. | $3.6B | 68 | Buy |
Peer medians: ROE -30.1% · P/E 27.0x · Gross margin 58.3%